189 related articles for article (PubMed ID: 35167675)
21. Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.
Jia G; Wen W; Massion PP; Shu XO; Zheng W
Carcinogenesis; 2021 Jun; 42(6):874-879. PubMed ID: 33640962
[TBL] [Abstract][Full Text] [Related]
22. How the Expansion of the U.S. Preventive Services Task Force Lung Cancer Screening Eligibility May Improve Health Equity Among Diverse Sexual and Gender Minority Populations.
Tan ASL; Potter J
LGBT Health; 2021 Nov; 8(8):503-506. PubMed ID: 34619037
[TBL] [Abstract][Full Text] [Related]
23. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
24. Cross sectional study to assess the accuracy of electronic health record data to identify patients in need of lung cancer screening.
Cole AM; Pflugeisen B; Schwartz MR; Miller SC
BMC Res Notes; 2018 Jan; 11(1):14. PubMed ID: 29321038
[TBL] [Abstract][Full Text] [Related]
25. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
27. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
29. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
[TBL] [Abstract][Full Text] [Related]
30. Assessing, updating and utilising primary care smoking records for lung cancer screening.
McCutchan G; Engela-Volker J; Anyanwu P; Brain K; Abel N; Eccles S
BMC Pulm Med; 2023 Nov; 23(1):445. PubMed ID: 37974137
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
[TBL] [Abstract][Full Text] [Related]
33. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking.
Li CC; Matthews AK; Rywant MM; Hallgren E; Shah RC
Cancer Causes Control; 2019 Mar; 30(3):235-240. PubMed ID: 30377905
[TBL] [Abstract][Full Text] [Related]
34. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
35. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
Li J; Chung S; Wei EK; Luft HS
BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines.
Pinheiro LC; Groner L; Soroka O; Prosper AE; Jack K; Tamimi RM; Safford M; Phillips E
JAMA Netw Open; 2022 Sep; 5(9):e2229741. PubMed ID: 36053535
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
Aldrich MC; Mercaldo SF; Sandler KL; Blot WJ; Grogan EL; Blume JD
JAMA Oncol; 2019 Sep; 5(9):1318-1324. PubMed ID: 31246249
[TBL] [Abstract][Full Text] [Related]
38. Treatment capacity required for full-scale implementation of lung cancer screening in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Cancer; 2019 Jun; 125(12):2039-2048. PubMed ID: 30811590
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of cigarette and e-cigarette use among U.S. adults eligible for lung cancer screening based on updated USPSTF guidelines.
Heiden BT; Engelhardt KE; Cao C; Meyers BF; Puri V; Cao Y; Kozower BD
Cancer Epidemiol; 2022 Feb; 76():102079. PubMed ID: 34894590
[TBL] [Abstract][Full Text] [Related]
40. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
; Krist AH; Davidson KW; Mangione CM; Barry MJ; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Kubik M; Landefeld CS; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
JAMA; 2021 Mar; 325(10):962-970. PubMed ID: 33687470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
